PMID- 37845488 OWN - NLM STAT- MEDLINE DCOM- 20240320 LR - 20240321 IS - 1740-634X (Electronic) IS - 0893-133X (Print) IS - 0893-133X (Linking) VI - 49 IP - 5 DP - 2024 Apr TI - Physiological acetic acid concentrations from ethanol metabolism stimulate accumbens shell medium spiny neurons via NMDAR activation in a sex-dependent manner. PG - 885-892 LID - 10.1038/s41386-023-01752-8 [doi] AB - Recent studies have implicated the ethanol metabolite, acetic acid, as neuroactive, perhaps even more so than ethanol itself. In this study, we investigated sex-specific metabolism of ethanol (1, 2, and 4 g/kg) to acetic acid in vivo to guide electrophysiology experiments in the accumbens shell (NAcSh), a key node in the mammalian reward circuit. There was a sex-dependent difference in serum acetate production, quantified via ion chromatography only at the lowest dose of ethanol (males > females). Ex vivo electrophysiology recordings of NAcSh medium spiny neurons (MSN) in brain slices demonstrated that physiological concentrations of acetic acid (2 mM and 4 mM) increased NAcSh MSN excitability in both sexes. N-methyl-D-aspartate receptor (NMDAR) antagonists, AP5 and memantine, robustly attenuated the acetic acid-induced increase in excitability. Acetic acid-induced NMDAR-dependent inward currents were greater in females compared to males and were not estrous cycle dependent. These findings suggest a novel NMDAR-dependent mechanism by which the ethanol metabolite, acetic acid, may influence neurophysiological effects in a key reward circuit in the brain from ethanol consumption. Furthermore, these findings also highlight a specific sex-dependent sensitivity in females to acetic acid-NMDAR interactions. This may underlie their more rapid advancement to alcohol use disorder and increased risk of alcohol related neurodegeneration compared to males. CI - (c) 2023. The Author(s), under exclusive licence to American College of Neuropsychopharmacology. FAU - Chapp, Andrew D AU - Chapp AD AD - Department of Neuroscience, University of Minnesota, Minneapolis, MN, 55455, USA. AD - Medical Discovery Team on Addiction, University of Minnesota, Minneapolis, MN, 55445, USA. FAU - Nwakama, Chinonso A AU - Nwakama CA AUID- ORCID: 0000-0002-5167-7949 AD - Department of Neuroscience, University of Minnesota, Minneapolis, MN, 55455, USA. AD - Medical Discovery Team on Addiction, University of Minnesota, Minneapolis, MN, 55445, USA. AD - Medical Scientist Training Program, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA. FAU - Collins, Andrea R AU - Collins AR AD - Department of Psychiatry, University of California San Francisco Fresno, Fresno, CA, 93701, USA. FAU - Mermelstein, Paul G AU - Mermelstein PG AD - Department of Neuroscience, University of Minnesota, Minneapolis, MN, 55455, USA. pmerm@umn.edu. AD - Medical Discovery Team on Addiction, University of Minnesota, Minneapolis, MN, 55445, USA. pmerm@umn.edu. AD - Center for Neural Circuits in Addiction, University of Minnesota, Minneapolis, MN, 55455, USA. pmerm@umn.edu. FAU - Thomas, Mark J AU - Thomas MJ AUID- ORCID: 0000-0001-5721-5350 AD - Department of Neuroscience, University of Minnesota, Minneapolis, MN, 55455, USA. tmhomas@umn.edu. AD - Medical Discovery Team on Addiction, University of Minnesota, Minneapolis, MN, 55445, USA. tmhomas@umn.edu. AD - Center for Neural Circuits in Addiction, University of Minnesota, Minneapolis, MN, 55455, USA. tmhomas@umn.edu. LA - eng GR - T32 DA007234/DA/NIDA NIH HHS/United States PT - Journal Article DEP - 20231016 PL - England TA - Neuropsychopharmacology JT - Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology JID - 8904907 RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - 3K9958V90M (Ethanol) SB - IM UOF - bioRxiv. 2023 May 05;:. PMID: 37205358 MH - Animals MH - Female MH - Male MH - *Nucleus Accumbens MH - *Neurons/metabolism MH - Receptors, N-Methyl-D-Aspartate/metabolism MH - Medium Spiny Neurons MH - Ethanol/pharmacology MH - Mammals/metabolism PMC - PMC10948831 COIS- The authors declare no competing interests. EDAT- 2023/10/17 00:42 MHDA- 2024/03/20 06:45 PMCR- 2025/04/01 CRDT- 2023/10/16 23:39 PHST- 2023/05/08 00:00 [received] PHST- 2023/10/02 00:00 [accepted] PHST- 2023/09/05 00:00 [revised] PHST- 2025/04/01 00:00 [pmc-release] PHST- 2024/03/20 06:45 [medline] PHST- 2023/10/17 00:42 [pubmed] PHST- 2023/10/16 23:39 [entrez] AID - 10.1038/s41386-023-01752-8 [pii] AID - 1752 [pii] AID - 10.1038/s41386-023-01752-8 [doi] PST - ppublish SO - Neuropsychopharmacology. 2024 Apr;49(5):885-892. doi: 10.1038/s41386-023-01752-8. Epub 2023 Oct 16.